A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/047 (2006.01) A61K 31/40 (2006.01) A61K 31/496 (2006.01) A61K 31/54 (2006.01) A61K 31/7004 (2006.01) A61K 31/702 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2682736
It is intended to provide a novel therapeutic or preventive method which exhibits an excellent anti-obesity effect (an effect of reducing body fat and/or an effect of reducing body fat) and a pharmaceutical composition, and use thereof. The pharmaceutical composition comprising a dipeptidyl peptidase IV inhibitor compound and a sweetener having an action of promoting GLP-1 secretion in combination, and the use thereof in the production of a pharmaceutical. Further, the therapeutic or preventive method for obesity, characterized by administering an effective amount of (a) a dipeptidyl peptidase IV inhibitor compound and (b) a sweetener having an action of promoting GLP-1 secretion to a patient with obesity symptoms.
L'invention concerne la fourniture d'un nouveau procédé thérapeutique ou de prévention qui présente un excellent effet anti-obésité (un effet de réduction de tissu adipeux), et d'une composition pharmaceutique, et leur utilisation. L'invention concerne la composition pharmaceutique comprenant un composé inhibiteur de dipeptidylpeptidase IV et un adoucisseur ayant une action de promotion de sécrétion de GLP-1 en combinaison, et son utilisation dans la production d'un produit pharmaceutique. De plus, l'invention concerne le procédé thérapeutique contre l'obésité ou de prévention de l'obésité, caractérisé par l'administration d'une quantité efficace (a) d'un composé inhibiteur de dipeptidylpeptidase IV, et (b) d'un adoucisseur ayant une action de promotion de sécrétion de GLP-1, à un patient souffrant des symptômes d'obésité.
Ishihara Tomomi
Matsushita Chiaki
Shiotani Masaharu
Marks & Clerk
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Combined use of dipeptidyl peptidase 4 inhibitor and sweetener does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined use of dipeptidyl peptidase 4 inhibitor and sweetener, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined use of dipeptidyl peptidase 4 inhibitor and sweetener will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1894723